drugset / Trial / NCT01006499

Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'

NCT01006499

RandomizedFactorialQuadruple-blindTreatment

Summary

The investigators aim is to investigate whether adjuvant Pentoxifylline , IgM enriched IVIG or Pentoxifylline plus IgM-enriched IVIG reduced mortality from Neonatal sepsis.

Timeline

Start
2009-08
Primary completion
2010-10
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentaglobin Protein / enzyme biologic 250 mg/kg Intravenous
Comparator Pentoxifylline Small molecule 6 mg/kg Intravenous

Indications